Skip to content

Clinical trials

Terminated Phase 2 Breast Carcinoma In Situ trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Carcinoma In Situ Phase: Phase 2 Status: Terminated Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20022
20041
20051
20061
20091
20131
20141
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mayo Clinic2
Dana-Farber Cancer Institute1
Eastern Cooperative Oncology Group1
Jonsson Comprehensive Cancer Center1
Masonic Cancer Center, University of Minnesota1
Roswell Park Cancer Institute1
SWOG Cancer Research Network1
University of Texas Southwestern Medical Center1
Vanderbilt-Ingram Cancer Center1
Virginia Commonwealth University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Carcinoma In Situ12
Breast Neoplasms10
Carcinoma, Intraductal, Noninfiltrating6
Carcinoma, Ductal, Breast2
Carcinoma, Lobular1
Fatigue1
Fibrocystic Breast Disease1
Hot Flashes1
Radiation Injuries1
Triple Negative Breast Neoplasms1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.